Se Jin Kim

Se Jin Kim

Auto-generated profile, based on publicly available information

Se Jin Kim

Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SJSun Young Joo
Sun Young Joo
SJSeung Hyun Jang
Seung Hyun Jang
JKJung Ah Kim
Jung Ah Kim
SKSe Jin Kim
Se Jin Kim
BKBonggi Kim
Bonggi Kim
JJJinsei Jung
Jinsei Jung
Joo SY, et al. J Korean Med Sci. 2023 Nov;38:e355. https://doi.org/10.3346/jkms.2023.38.e355

29 September 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SJSun Young Joo
Sun Young Joo
SJSeung Hyun Jang
Seung Hyun Jang
JKJung Ah Kim
Jung Ah Kim
SKSe Jin Kim
Se Jin Kim
JCJae Young Choi
Jae Young Choi
HGHeon Yung Gee
Heon Yung Gee
Hearing loss is genetically heterogeneous, with over 121 implicated genes. Minor allele frequency (MAF) data from population databases greatly aid variant interpretation; however, these databases are predominantly based on individuals of European ancestry and lack sufficient East Asian representation, limiting accurate interpretation in under-represented populations. We analyzed rare variants associated with non-syndromic hearing loss classified as pathogenic, likely pathogenic, or of uncertain significance in the Deafness Variation Database (DVD). Population allele frequencies from 9,579 Koreans, 54,000 Japanese, and 651 patients with sensorineural hearing loss were evaluated. Of the 6,381 pathogenic or likely pathogenic variants cataloged in the DVD, 216 (3.38%) were detected in Korean population. Among these, 31 variants exhibited high allele frequencies that exceeded thresholds typically applied to identify benign variants in clinical interpretation guidelines. Of these, 6 remained disease-causing, including 4 East Asian founder alleles and one MYO7A variant common in Koreans. Our pipeline identified 24 variants for reclassification as benign or likely benign, and one P2RX2 variant of uncertain significance. Of 1,299,211 VUS, 3,736 were reclassified as benign. A substantial number of variants previously classified as pathogenic were reclassified as benign using MAF data from under-represented populations, highlighting the need for large-scale sequencing in diverse ancestries.